National Cancer Institute-supported clinical trials group was founded in 1995 to support innovative trials for AIDS-associated malignancies.
The Melanoma Research Foundation Breakthrough Consortium (MRFBC) is a Melanoma Research Foundation-supported clinical trials group founded in 2010.
The National MDS Study will build a resource that will enable scientists to conduct research to improve the way MDS is diagnosed and how it is treated
CTIMS provides information support, statistical support, and data management for extramural/intergroup and expanded access trials sponsored by CTEP.
NCI Central Institutional reduces the administrative burden on local IRBs and investigators while continuing a high level of protection for human research participants.